This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2022 Information Coming Soon!

Francesca Zammarchi, PhD
Head of Pharmacology at ADC Therapeutics


Dr. Francesca Zammarchi is Head of Pharmacology at ADC Therapeutics.

She has 15+ years’ experience in cancer research and has published multiple papers, in peer-reviewed international scientific journals.

Dr. Zammarchi is a graduate from the University of Pisa where she received her PhD in Experimental and Molecular Oncology. Subsequently she has spent eight years as a Research Associate in the Molecular Pharmacology and Chemistry Department of Memorial Sloan Kettering Cancer Center, New York, U.S.A. During this time she successfully contributed to the development and optimization of small molecule drugs for the targeted treatment of cancer.

Agenda Sessions

  • Antibody-drug Conjugates as Immunotherapeutic Agents: Development of a CD25-targeted, PBD-based ADC Targeting T Regulatory Immune Cells in Pre-clinical Models of Solid Cancer

    On Demand
  • Payloaded Antibodies and Immune-oncology – Crossroads